Sequence:39-amino-acid synthetic triagonist peptide (fatty-acid-modified) Origin: Engineered triple incretin analogue developed as a single-molecule agonist at GIP, GLP-1 and glucagon receptors
Retatrutide is a triple agonist (GIP, GLP-1, and glucagon receptors) while Ozempic activates only GLP-1 receptors, resulting in significantly greater weight loss, 24.2% versus 14.9% at standard doses
GLP-1 neurons in the nucleus tractus solitarius widely project to the central nervous system, including the hypothalamus (paraventricular nucleus, supraoptic nucleus, arcuate nucleus, and hypothalamic dorsomedial nucleus), brainstem (parabrachial nucleus, reticular formation, dorsal vagal nucleus), thalamus, and intermedio-lateral cell column
Some of these risk factors include high cholesterol, obesity, and diabetes
Insulin is a fat storing hormone